This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: University of Massachusetts. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: Byoung Heon Kang: Innovator in Mitochondria-Targeted Anti-Tumor Agents
Introduction
Byoung Heon Kang is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of anti-tumor agents, focusing on innovative methods for treating disorders associated with unwanted cell proliferation. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
Kang's latest patents include groundbreaking research on mitochondria-targeted anti-tumor agents. These patents describe methods of making and using these agents for the treatment of various disorders linked to unwanted cell growth. His innovative approach aims to enhance the efficacy of cancer therapies by specifically targeting mitochondria within cells.
Career Highlights
Byoung Heon Kang is affiliated with the University of Massachusetts, where he continues to push the boundaries of cancer research. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from various forms of cancer.
Collaborations
Kang collaborates with Dario C Altieri, a fellow researcher in the field. Their partnership exemplifies the importance of teamwork in advancing scientific knowledge and developing effective treatment strategies.
Conclusion
Byoung Heon Kang's contributions to the field of anti-tumor agents highlight his dedication to improving cancer treatment. His innovative research and collaborations are essential in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile